The scientist’s investigation covers issues in Internal medicine, Endocrinology, Bone remodeling, Bone resorption and Osteoblast. Internal medicine and Cancellous bone are commonly linked in his work. His research combines Osteocalcin and Endocrinology.
His Bone remodeling research incorporates elements of Osteoporosis and Mineralization. Russell T. Turner interconnects Leptin and Anatomy in the investigation of issues within Bone resorption. His biological study spans a wide range of topics, including Cellular differentiation, RANKL, Growth factor, Bone marrow and Alkaline phosphatase.
Russell T. Turner mostly deals with Internal medicine, Endocrinology, Cancellous bone, Bone remodeling and Osteoporosis. His Osteocalcin research extends to the thematically linked field of Internal medicine. His research in Endocrinology intersects with topics in Cortical bone and Osteoblast.
The various areas that Russell T. Turner examines in his Cancellous bone study include Bone growth, Metaphysis, Bone marrow and Leptin. His research integrates issues of Ethanol, Peak bone mass, Bone cell and Pathology in his study of Bone remodeling. His Bone resorption research includes themes of Bone disease and Resorption.
His primary areas of investigation include Internal medicine, Endocrinology, Cancellous bone, Bone remodeling and Osteoporosis. His study looks at the intersection of Internal medicine and topics like Osteocalcin with Dual-energy X-ray absorptiometry. His Endocrinology study combines topics from a wide range of disciplines, such as Cortical bone and Osteoblast.
His Cancellous bone study incorporates themes from Metaphysis, White adipose tissue, Lumbar vertebrae, Bone growth and Osteopenia. The Bone remodeling study combines topics in areas such as Ethanol, Surgery, N-terminal telopeptide and Pathology. His study in the field of Bone fragility also crosses realms of Clinical Practice.
Russell T. Turner focuses on Internal medicine, Endocrinology, Bone remodeling, Osteoporosis and Cancellous bone. Much of his study explores Internal medicine relationship to Cortical bone. As a part of the same scientific study, Russell T. Turner usually deals with the Endocrinology, concentrating on Bone marrow and frequently concerns with Bone growth.
His Bone remodeling research is multidisciplinary, relying on both Bone mineral, Surgery and Osteoblast. His studies in Osteoblast integrate themes in fields like Osteoclast and Adipocyte. Particularly relevant to Osteopenia is his body of work in Osteoporosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Skeletal Effects of Estrogen
Turner Rt;Riggs Bl;Spelsberg Tc.
Endocrine Reviews (1994)
Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells
H Dobnig;R T Turner.
ANDROGENS DIRECTLY STIMULATE PROLIFERATION OF BONE CELLS IN VITRO
C. H. Kasperk;J. E. Wergedal;J. R. Farley;T. A. Linkhart.
Leptin reduces ovariectomy-induced bone loss in rats.
Bartolome Burguera;Lorenz C. Hofbauer;Thierry Thomas;Francesca Gori.
The effects of ovariectomy and 17β-estradiol on cortical bone histomorphometry in growing rats
Russell T. Turner;Jacob J. Vandersteenhoven;Norman H. Bell.
Journal of Bone and Mineral Research (2009)
Parathyroid hormone stimulates bone formation and resorption in organ culture: evidence for a coupling mechanism.
Guy A. Howard;Brian L. Bottemiller;Russell T. Turner;Jeanne I. Rader.
Proceedings of the National Academy of Sciences of the United States of America (1981)
The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats
Harald Dobnig;Russell T. Turner.
Skeletal response to alcohol.
Russell T. Turner.
Alcoholism: Clinical and Experimental Research (2000)
Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone
Rachel M. Locklin;Sundeep Khosla;Russell T. Turner;B. Lawrence Riggs.
Journal of Cellular Biochemistry (2003)
Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
G A Howard;R T Turner;D J Sherrard;D J Baylink.
Journal of Biological Chemistry (1981)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: